CV Heart Failure Flashcards
Loop Diuretics
treat CHF + ADHF. reversibly inhibit NaKCl co-transporter. increase renal E Na H2O K Ca Mg Cl H and relax systemic venous to decrease preload. K loss unintended, most efficacious. treat chronic with oral and acute decompensation with IV. Adverse V depletion, hypokalemia - prone to arrhythmias. resistance occurs, overcome with thiazide diuretic or higher dose. potentiated by renin-angiotensin inhibitors
Thiazide Diuretics
treat CHF only. reversibly inhibit NaCl co-transporter. increase renal E of Na H2O K Mg Cl H, decrease E Ca. decrease preload, lower efficacy, oral admin. use with loop. Adverse V depletion, hypokalemia. potentiated by renin-angiotensin inhibitors
K+ sparing Diuretics
treat CHF. block Na channels. increase renal E Na H20 Cl. low efficacy alone. Adverse hyperkalemia
Aldosterone Antagonists
treat CHF. block expression Na channels. competitive antagonist. increase renal E Na H2O Cl. inhibit ventricular remodeling - slow progression HF. low efficacy alone but proven to prolong survival when added to treatment in severe CHF. Adverse hyperkalemia + gynecomastia
Renin-Angiotensin Inhibitors
treat CHF. decrease venous/arterial contraction and sympathetic activity, increase renal E Na H2O, reduce ventricular remodeling. proven to improve survival. Adverse hypotension, hyperkalemia, cough. No benefit to combining with each other only aldosterone antagonists
β Blockers
treat CHF. decrease ventricular remodeling, arrhythmias, cardiac work. oral very low dose, initially worsen then improve, not given to very severe. proven to prolong survival. Adverse bronchoconstriction. abrupt withdrawal precipitate angina
Direct Arterial Vasodilators
treat CHF. decrease arteriolar contraction, decrease afterload, decrease O2 consumption. proven to prolong survival with nitrate. need multiple daily doses. Adverse headache, dizziness. combo with nitrate preferable to renin-angio inhibitors in blacks
Nitrates
treat ADHF. decrease preload and afterload, decrease filling pressure, edema, cardiac work. IV or sublingual. no effect on survival alone. only used in combo. Adverse flushing hypotension. tolerance major problem, combine with ED drug
Digoxin
treat CHF. binds to NaK ATPase, inhibits Na out, increases intracellular Ca, increase contractility. primary benefit decrease sympathetic/increase parasympathetic. only severe HF or those with A-fib, no effect on survival. many adverse effects and drug interactions
β Agonists
treat ADHF. increase contractility and cardiac output, decrease filling pressure. decreases symptoms but no effect on survival. Adverse tachycardia, arrhythmia. tolerance possible
Phosphodiesterase Inhibitors
treat ADHF. increase cAMP in SR, increase intracellular Ca. increase rate of relaxation, contractility and cardiac output, decrease filling pressure. maintains circulatory stability, less likely to cause arrhythmia. Adverse hypotension. drug of choice with β blockers, chronically decreased survival
Vasopressin Antagonists
treat ADHF. blocks vasopressin R. increase plasma Na, reduce body weight, cardiac filling pressure, dyspnea. used to correct hyponatremia, no long term effects. Adverse constipation, dry mouth
Nesiritide
treat ADHF. decrease venous/arterial contraction, increase cardiac output. decreases dyspnea, but no effect on survival long term. Adverse hypotension. not really used
Diuretics for diastolic dysfunction
decrease preload, filling pressure and cardiac work allows good symptomatic relief. excessive decrease in filling pressure decreases cardiac output - big problem for already stiffened ventricles